Home › Premature Birth › NCT05229666
Stress Phenotypes and Preterm Birth
Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria * Pregnant women 18 years of age or older (based on self-report) * Not currently smoking, drinking alcohol, or taking drugs (based on self-report) * Planning to deliver at CUIMC/NYP (based on self-report) * In the first or second trimester of pregnancy (prior to 28 weeks gestation) (based on self-report of estimated date of delivery) Exclusion Criteria * Multi-fetal pregnancy (based on self-report) * Taking medications regularly that affect the cardiovascular and inflammatory systems, including NSAIDS and other anti-inflammatories, α blockers, β blockers, corticosteroids, chronic-use asthma medications (e.g. beta2- adrenoceptor agonists) (based on self-report) * This does NOT include baby aspirin or low-dose aspirin, as baby aspirin / low-dose aspirin is not normally considered to be an NSAID. * Inflammatory conditions including rheumatoid arthritis, lupus, and multiple sclerosis (based on self-report)
About the study
Pregnancy ends in preterm birth (PTB) for approximately 1 in 10 women, though more often for Non-Hispanic Black women, 14.12% PTB rate, compared to 9.09% for Non-Hispanic White women. Psychosocial stress and childhood trauma each are associated with risk for PTB and PTB has an intergenerational impact: mothers born preterm are more likely to give birth preterm, especially amongst Black women. In this project, we will study mitochondria, which contain their own genome, the mitochondria DNA, and are inherited from the mother, as they represent a potential intersection point between psychosocial experiences and their biological embedding in underlying disease outcomes such as PTB
What is being tested
- Cognitive Challenge (other)
Sponsor: Columbia University · Participants: 200 · Started: Dec 9, 2021
Contact the study team
- Catherine Monk, PhD · Phone: 646-774-8941
- Elizabeth Werner, PhD · Phone: 646-774-8835
Official record on ClinicalTrials.gov — NCT05229666
Locations in the U.S.
| New York | Columbia University Irving Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.